Autopsy report · NCT00559169

Verapamil and Catamenial Epilepsy

“protocol changed and a new study using verapamil in epilepsy will be started in the near future”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

University Health Network, Toronto

Sponsor type

University, hospital or other

Conditions

Catamenial Epilepsy

Interventions

verapamil hyrochloride

Participants

12 (planned, not actual)

Sites

1

Countries

Canada

Trials that died the same way

• A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants
  “Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.